India looks for test kits from South Korea

South Korea is proving out to be an important source of medical supplies for India among the countries for novel coronavirus with aggressive testing and contact tracing. The Indian embassy in Seoul signed an agreement for supply of 5,00,000 rapid test kits from a South Korean company to the ICMR.

According to the agreement, the kits will be delivered in 4 separate consignments, the first of which will reach India April 30.

The procurement will help scale up the availability of tests which is a “big weapon’’ in the fight against Covid-19 said, India’s ambassador to South Korea Sripriya Ranganathan

“It’s not a buyer’s market but the goodwill which India enjoys with the South Korean government and its people has meant that the manufacturers are much more receptive to our needs and more flexible in meeting our demands.”

Ranganathan further added that, ‘all procurement is certified for export and subject to quality checks. “These have been found suitable for use by the ICMR. The company with which the embassy has signed the agreement is sourcing raw materials for production of the diagnostic testing kits from India, a collaboration described as a tribute to the special strategic partnership between the 2 countries.”

“It wasn’t that the Koreans from the start had the option of walking up to a hospital and getting themselves tested. It was also very expensive initially but they built up their capacity over a period of time by making tests available. Over 2 months, they pumped more tests into their healthcare system and spread the net wide as out agencies are doing now in India,’’ she said.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Draft bill proposes powers for DIs to inspect online pharmacy office premises

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?